Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview

References

• Howard EJ, Vesper SJ, Guthrie BJ, et al. Asthma prevalence and mold levels in US northeastern schools. J Allergy Clin Immunol Pract. 2021;9(3):1312–1318.
   PubMed Web of Science ®Google Scholar
• Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246.
   PubMed Web of Science ®Google Scholar
• Devine JF. Chronic obstructive pulmonary disease: an overview. Am Heal Drug Benefits. 378 2008;1(7):34–42
   PubMedGoogle Scholar
• Hikichi M, Hashimoto S, Gon Y. Asthma and COPD overlap pathophysiology of ACO. Allergol Int. 2018;67(2):179–186.
   PubMed Web of Science ®Google Scholar
• Freiler JF. The asthma-COPD overlap syndrome. Fed Pract. 2015;32(10):19S–23S.
   PubMedGoogle Scholar
• Tu X, Donovan C, Kim RY, et al. Asthma-COPD overlap: current understanding and the utility of experimental models. Eur Respir Rev. 2021;30(159):190185.
   PubMed Web of Science ®Google Scholar
• Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics. 2001;2(3):155–168.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29(11):1181–1189.
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Wang P, et al. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137(2):293–300.
   PubMed Web of Science ®Google Scholar
• Amberg A, Riefke B, Schlotterbeck G, et al. NMR and MS methods for metabolomics. Methods Mol Biol. 2017;1641:229–258.
   PubMedGoogle Scholar
• Fan TWM, Lane AN. Applications of NMR spectroscopy to systems biochemistry. Prog Nucl Magn Reson Spectrosc. 2016;92–93:18–53.
   PubMed Web of Science ®Google Scholar
• Bingol K, Bruschweiler-Li L, Yu C, et al. Metabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixtures. Anal Chem. 2015;87(7):3864–3870.
   PubMed Web of Science ®Google Scholar
• Hautbergue GM, Golovanov AP. Increasing the sensitivity of cryoprobe protein NMR experiments by using the sole low-conductivity arginine glutamate salt. J Magn Reson. 2008;191(2):335–339.
   PubMed Web of Science ®Google Scholar
• Emwas A-HM. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol Biol. 2015;1277:161–193.
   PubMedGoogle Scholar
• Perez ER, Knapp JA, Horn CK, et al. Comparison of LC-MS-MS and GC-MS analysis of benzodiazepine compounds included in the drug demand reduction urinalysis program. J Anal Toxicol. 2016;40(3):201–207.
   PubMed Web of Science ®Google Scholar
• Mittal RD. Tandem mass spectroscopy in diagnosis and clinical research. Indian J Clin Biochem. 2015;30(2):121–123.
   PubMedGoogle Scholar
• Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451–459.
   PubMed Web of Science ®Google Scholar
• Di Minno A, Gelzo M, Stornaiuolo M, et al. The evolving landscape of untargeted metabolomics. Nutr Metab Cardiovasc Dis. 2021;31(6):1645–1652.
   PubMed Web of Science ®Google Scholar
• Saito R, Sugimoto M, Hirayama A, et al. Quality assessment of untargeted analytical data in a large-scale metabolomic study. J Clin Med. 2021;10(9):1826.
   PubMed Web of Science ®Google Scholar
• Gertsman I, Barshop BA. Promises and pitfalls of untargeted metabolomics. J Inherit Metab Dis. 2018;41(3):355–366.
   PubMed Web of Science ®Google Scholar
• Cao G, Song Z, Hong Y, et al. Large-scale targeted metabolomics method for metabolite profiling of human samples. Anal Chim Acta. 2020;1125:144–151.
   PubMed Web of Science ®Google Scholar
• Bingol K. Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR methods. High-throughput. 2018;7(2):9.
   PubMedGoogle Scholar
• Klupczyńska A, Dereziński P, Kokot ZJ. Metabolomics in medical sciences–trends, challenges and perspectives. Acta Pol Pharm. 2015;72(4):629–641.
   PubMed Web of Science ®Google Scholar
• Gauglitz JM, West KA, Bittremieux W, et al. Enhancing untargeted metabolomics using metadata-based source annotation. Nat Biotechnol. 2022. https://doi.org/10.1038/s41587-022-01368-1
   Google Scholar
• Zhou Z, Luo M, Chen X, et al. Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics. Nat Commun. 2020;11(1):4334.
   PubMed Web of Science ®Google Scholar
• Horai H, Arita M, Kanaya S, et al. MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 2010;45(7):703–714.
   PubMed Web of Science ®Google Scholar
• Smith CA, O’Maille G, Want EJ, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27(6):747–751.
   PubMed Web of Science ®Google Scholar
• Kirwan JA, Weber RJM, Broadhurst DI, et al. Direct infusion mass spectrometry metabolomics dataset: a benchmark for data processing and quality control. Sci Data. 2014;1:140012.
   PubMed Web of Science ®Google Scholar
• Wolahan SM, Hirt D, Glenn TC. Translational metabolomics of head injury: exploring dysfunctional cerebral metabolism with ex vivo NMR spectroscopy-based metabolite quantification. In: Kobeissy FH, editor. Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects. Boca Raton (FL) CRC Press; 2015:371–378.
   Google Scholar
• Korthauer K, Kimes PK, Duvallet C, et al. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20(1):118.
   PubMed Web of Science ®Google Scholar
• Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69–71.
   PubMed Web of Science ®Google Scholar
• Meinicke P, Lingner T, Kaever A, et al. Metabolite-based clustering and visualization of mass spectrometry data using one-dimensional self-organizing maps. Algorithms Mol Biol. 2008;3:9.
   PubMed Web of Science ®Google Scholar
• Wieder C, Frainay C, Poupin N, et al. Pathway analysis in metabolomics: recommendations for the use of over-representation analysis. PLoS Comput Biol. 2021;17(9):e1009105.
   PubMed Web of Science ®Google Scholar
• Mitrea C, Taghavi Z, Bokanizad B, et al. Methods and approaches in the topology-based analysis of biological pathways. Front Physiol. 2013;4:278.
   PubMed Web of Science ®Google Scholar
• Picart-Armada S, Fernández-Albert F, Vinaixa M, et al. FELLA: an R package to enrich metabolomics data. BMC Bioinformatics. 2018;19(1):538.
   PubMedGoogle Scholar
• Debik J, Sangermani M, Wang F, et al. Multivariate analysis of NMR-based metabolomic data. NMR Biomed. 2022;35(2):e4638.
   PubMed Web of Science ®Google Scholar
• Pomyen Y, Wanichthanarak K, Poungsombat P, et al. Deep metabolome: applications of deep learning in metabolomics. Comput Struct Biotechnol J. 2020;18:2818–2825.
   PubMed Web of Science ®Google Scholar
• Chiu CY, Lin G, Cheng ML, et al. Longitudinal urinary metabolomic profiling reveals metabolites for asthma development in early childhood. Pediatr Allergy Immunol. 2018;29(5):496–503.
   PubMed Web of Science ®Google Scholar
• Chiu CY, Cheng ML, Chiang MH, et al. Metabolomic analysis reveals distinct profiles in the plasma and urine associated with IgE reactions in childhood asthma. J Clin Med. 2020;9(3):887.
   PubMed Web of Science ®Google Scholar
• Khamis MM, Holt T, Awad H, et al. Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD. Metabolomics. 2018;14(9):115.
   PubMed Web of Science ®Google Scholar
• Chiu CY, Cheng ML, Chiang MH, et al. Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthma. Pediatr Allergy Immunol. 2019;30(7):689–697.
   PubMed Web of Science ®Google Scholar
• Zheng P, Zhang K, Lv X, et al. Gut microbiome and metabolomics profiles of allergic and non-allergic childhood asthma. J Asthma Allergy. 2022;15:419–435.
   PubMed Web of Science ®Google Scholar
• Chiu CY, Cheng ML, Chiang MH, et al. Integrated metabolic and microbial analysis reveals host-microbial interactions in IgE-mediated childhood asthma. Sci Rep. 2021;11(1):23407.
   PubMed Web of Science ®Google Scholar
• Sinha A, Desiraju K, Aggarwal K, et al. Exhaled breath condensate metabolome clusters for endotype discovery in asthma. J Transl Med. 2017;15(1):262.
   PubMedGoogle Scholar
• Maniscalco M, Paris D, Melck DJ, et al. Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study. Eur Respir J. 2018;51(3):1701825.
   PubMed Web of Science ®Google Scholar
• Maniscalco M, Motta A. Clinical and inflammatory phenotyping: can electronic nose and NMR-based metabolomics work at the bedside? Arch Med Res. 2018;49(1):74–76.
   PubMed Web of Science ®Google Scholar
• Ntontsi P, Ntzoumanika V, Loukides S, et al. EBC metabolomics for asthma severity. J Breath Res. 2020;14(3):36007.
   Web of Science ®Google Scholar
• Tao JL, Chen YZ, Dai QG, et al. Urine metabolic profiles in paediatric asthma. Respirology. 2019;24(6):572–581.
   PubMed Web of Science ®Google Scholar
• Li S, Liu J, Zhou J, et al. Urinary metabolomic profiling reveals biological pathways and predictive signatures associated with childhood asthma. J Asthma Allergy. 2020;13:713–724.
   PubMed Web of Science ®Google Scholar
• Papamichael MM, Katsardis C, Erbas B, et al. Urinary organic acids as biomarkers in the assessment of pulmonary function in children with asthma. Nutr Res. 2019;61:31–40.
   PubMed Web of Science ®Google Scholar
• Papamichael MM, Katsardis C, Tsoukalas D, et al. Plasma lipid biomarkers in relation to BMI, lung function, and airway inflammation in pediatric asthma. Metabolomics. 2021;17(7):63.
   PubMed Web of Science ®Google Scholar
• Liao SY, Linderholm A, Showalter MR, et al. L-arginine as a potential GLP-1-mediated immunomodulator of Th17-related cytokines in people with obesity and asthma. Obes Sci Pract. 2021;7(3):339–345.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng J, Zhang HP, et al. Obesity-associated metabolic signatures correlate to clinical and inflammatory profiles of asthma: a pilot study. Allergy Asthma Immunol Res. 2018;10(6):628–647.
   PubMed Web of Science ®Google Scholar
• Schleich FN, Zanella D, Stefanuto PH, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma. Am J Respir Crit Care Med. 2019;200(4):444–453.
   PubMed Web of Science ®Google Scholar
• Sola-Martínez RA, Lozano-Terol G, Gallego-Jara J, et al. Exhaled volatilome analysis as a useful tool to discriminate asthma with other coexisting atopic diseases in women of childbearing age. Sci Rep. 2021;11(1):13823.
   PubMed Web of Science ®Google Scholar
• Chawes BL, Giordano G, Pirillo P, et al. Neonatal urine metabolic profiling and development of childhood asthma. Metabolites. 2019;9(9):185.
   PubMed Web of Science ®Google Scholar
• Kolmert J, Gómez C, Balgoma D, et al. Urinary leukotriene E4 and prostaglandin D2 metabolites increase in adult and childhood severe asthma characterized by type 2 inflammation. Am J Respir Crit Care Med. 2021;203(1):37–53.
   PubMed Web of Science ®Google Scholar
• Reinke SN, Naz S, Chaleckis R, et al. Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. Eur Respir J. 2022;59(6):2101733.
   PubMed Web of Science ®Google Scholar
• Carraro S, Bozzetto S, Giordano G, et al. Wheezing preschool children with early-onset asthma reveal a specific metabolomic profile. Pediatr Allergy Immunol. 2018;29(4):375–382.
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Liu X, et al. Untargeted metabolomic study of acute exacerbation of pediatric asthma via HPLC-Q-Orbitrap-MS. J Pharm Biomed Anal. 2022;215:114737.
   PubMed Web of Science ®Google Scholar
• Khamis MM, Adamko DJ, Purves RW, et al. Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach. Anal Chim Acta. 2019;1047:81–92.
   PubMed Web of Science ®Google Scholar
• Khamis MM, Adamko DJ, El-Aneed A. Development of a validated LC-MS/MS method for the quantification of 19 endogenous asthma/COPD potential urinary biomarkers. Anal Chim Acta. 2017;989:45–58.
   PubMed Web of Science ®Google Scholar
• Teoh ST, Leimanis-Laurens ML, Comstock SS, et al. Combined plasma and urinary metabolomics uncover metabolic perturbations associated with severe respiratory syncytial viral infection and future development of asthma in infant patients. Metabolites. 2022;12(2):178.
   PubMed Web of Science ®Google Scholar
• Bai-Tong SS, Thoemmes MS, Weldon KC, et al. The impact of maternal asthma on the preterm infants’ gut metabolome and microbiome (MAP study). Sci Rep. 2022;12(1):6437.
   PubMed Web of Science ®Google Scholar
• Lee-Sarwar K, Dedrick S, Momeni B, et al. Association of the gut microbiome and metabolome with wheeze frequency in childhood asthma. J Allergy Clin Immunol. 2022;150(2):325–336.
   PubMed Web of Science ®Google Scholar
• Kelly RS, Virkud Y, Giorgio R, et al. Metabolomic profiling of lung function in Costa-Rican children with asthma. Biochim Biophys Acta Mol Basis Dis. 2017;1863(6):1590–1595.
   PubMed Web of Science ®Google Scholar
• Rago D, Rasmussen MA, Lee-Sarwar KA, et al. Fish-oil supplementation in pregnancy, child metabolomics and asthma risk. EBioMedicine. 2019;46:399–410.
   PubMed Web of Science ®Google Scholar
• Lee-Sarwar K, Kelly RS, Lasky-Su J, et al. Dietary and plasma polyunsaturated fatty acids are inversely associated with asthma and atopy in early childhood. J Allergy Clin Immunol Pract. 2019;7(2):529–538.e8.
   PubMed Web of Science ®Google Scholar
• Jiang T, Dai L, Li P, et al. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(2):158853.
   PubMed Web of Science ®Google Scholar
• Wang S, Tang K, Lu Y, et al. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clin Chim Acta. 2021;513:34–42.
   PubMed Web of Science ®Google Scholar
• Freeman A, Cellura D, Minnion M, et al. Exercise training induces a shift in extracellular redox status with alterations in the pulmonary and systemic redox landscape in asthma. Antioxidants (Basel). 2021;10(12):1926.
   PubMedGoogle Scholar
• Song Z, Yan W, Abulikemu M, et al. Sphingolipid profiles and their relationship with inflammatory factors in asthmatic patients of different sexes. Chronic Dis Transl Med. 2021;7(3):199–205.
   PubMedGoogle Scholar
• Kelly RS, Sordillo JE, Lasky-Su J, et al. Plasma metabolite profiles in children with current asthma. Clin Exp Allergy. 2018;48(10):1297–1304.
   PubMed Web of Science ®Google Scholar
• Reinke SN, Gallart-Ayala H, Gómez C, et al. Metabolomics analysis identifies different metabotypes of asthma severity. Eur Respir J. 2017;49(3):1601740.
   PubMed Web of Science ®Google Scholar
• Gai XY, Zhang LJ, Chang C, et al. Metabolomic analysis of serum glycerophospholipid levels in eosinophilic and neutrophilic asthma. Biomed Environ Sci. 2019;32(2):96–106.
   PubMed Web of Science ®Google Scholar
• Bian X, Sun B, Zheng P, et al. Derivatization enhanced separation and sensitivity of long chain-free fatty acids: application to asthma using targeted and non-targeted liquid chromatography-mass spectrometry approach. Anal Chim Acta. 2017;989:59–70.
   PubMed Web of Science ®Google Scholar
• Crestani E, Harb H, Charbonnier LM, et al. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol. 2020;145(3):897–906.
   PubMed Web of Science ®Google Scholar
• Zheng P, Bian X, Zhai Y, et al. Metabolomics reveals a correlation between hydroxyeicosatetraenoic acids and allergic asthma: evidence from three years’ immunotherapy. Pediatr Allergy Immunol. 2021;32(8):1654–1662.
   PubMed Web of Science ®Google Scholar
• Liang Y, Gai XY, Chang C, et al. Metabolomic profiling differences among asthma, COPD, and healthy subjects: a LC-MS-based metabolomic analysis. Biomed Environ Sci. 2019;32(9):659–672.
   PubMed Web of Science ®Google Scholar
• Guo C, Sun L, Zhang L, et al. Serum sphingolipid profile in asthma. J Leukoc Biol. 2021;110(1):53–59.
   PubMed Web of Science ®Google Scholar
• Matysiak J, Klupczynska A, Packi K, et al. Alterations in serum-free amino acid profiles in childhood asthma. Int J Environ Res Public Health. 2020;17(13):4758.
   PubMed Web of Science ®Google Scholar
• Zhou B, Jiang GT, Liu H, et al. Dysregulated arginine metabolism in young patients with chronic persistent asthma and in human bronchial epithelial cells. Nutrients. 2021;13(11):4116.
   PubMed Web of Science ®Google Scholar
• Lee Y, Chen H, Chen W, et al. Metabolomic associations of asthma in the hispanic community health study/study of Latinos. Metabolites. 2022;12(4):359.
   PubMed Web of Science ®Google Scholar
• Pang Z, Wang G, Wang C, et al. Serum metabolomics analysis of asthma in different inflammatory phenotypes: a cross-sectional study in northeast China. Biomed Res Int. 2018;2018:2860521.
   PubMed Web of Science ®Google Scholar
• Johnson RK, Brunetti T, Quinn K, et al. Discovering metabolite quantitative trait loci in asthma using an isolated population. J Allergy Clin Immunol. 2022;149(5):1807–1811.e16.
   PubMed Web of Science ®Google Scholar
• Liao J, Gheissari R, Thomas DC, et al. Transcriptomic and metabolomic associations with exposures to air pollutants among young adults with childhood asthma history. Environ Pollut. 2022;299:118903.
   PubMed Web of Science ®Google Scholar
• Fujiogi M, Camargo CAJ, Raita Y, et al. Integrated associations of nasopharyngeal and serum metabolome with bronchiolitis severity and asthma: a multicenter prospective cohort study. Pediatr Allergy Immunol. 2021;32(5):905–916.
   PubMed Web of Science ®Google Scholar
• Liu A, Ma T, Xu NJ, et al. Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome. Microbiol Spectr. 2021;9(2):e0085921.
   PubMed Web of Science ®Google Scholar
• Gürdeniz G, Ernst M, Rago D, et al. Neonatal metabolome of caesarean section and risk of childhood asthma. Eur Respir J. 2022;59(6):2102406.
   PubMed Web of Science ®Google Scholar
• Cruickshank-Quinn C, Armstrong M, Powell R, et al. Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate. Respir Res. 2017;18(1):57.
   PubMedGoogle Scholar
• Schmidt AJ, Borras E, Nguyen AP, et al. Portable exhaled breath condensate metabolomics for daily monitoring of adolescent asthma. J Breath Res. 2020;14(2):26001.
   Web of Science ®Google Scholar
• Tian M, Chen M, Bao YL, et al. Sputum metabolomic profiling of bronchial asthma based on quadruple time-of-flight mass spectrometry. Int J Clin Exp Pathol. 2017;10(10):10363–10373.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Camargo CAJ, Raita Y, et al. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2022;149(1):102–112.
   PubMed Web of Science ®Google Scholar
• Ravi A, Goorsenberg AWM, Dijkhuis A, et al. Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty. J Allergy Clin Immunol. 2021;148(5):1236–1248.
   PubMed Web of Science ®Google Scholar
• Fortis S, Lusczek ER, Weinert CR, et al. Metabolomics in COPD acute respiratory failure requiring noninvasive positive pressure ventilation. Can Respir J. 2017;2017:9480346.
   PubMed Web of Science ®Google Scholar
• Prokić I, Lahousse L, de Vries M, et al. A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease. BMC Pulm Med. 2020;20(1):193.
   PubMed Web of Science ®Google Scholar
• Diao W, Labaki WW, Han MK, et al. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2015–2025.
   PubMed Web of Science ®Google Scholar
• Labaki WW, Gu T, Murray S, et al. Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study. Sci Rep. 2019;9(1):11367.
   PubMedGoogle Scholar
• Zheng H, Hu Y, Dong L, et al. Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least-squares support vector machine. J Clin Lab Anal. 2021;35(2):e23641.
   PubMed Web of Science ®Google Scholar
• Choudhury P, Bhattacharya A, Dasgupta S, et al. Identification of novel metabolic signatures potentially involved in the pathogenesis of COPD associated pulmonary hypertension. Metabolomics. 2021;17(10):94.
   PubMed Web of Science ®Google Scholar
• Maniscalco M, Paris D, Cuomo P, et al. Metabolomics of COPD pulmonary rehabilitation outcomes via exhaled breath condensate. Cells. 2022;11(3):344.
   PubMed Web of Science ®Google Scholar
• Muñoz-Lucas MÁ, Jareño-Esteban J, Gutiérrez-Ortega C, et al. Influence of chronic obstructive pulmonary disease on volatile organic compounds in patients with non-small cell lung cancer. Arch Bronconeumol. 2020;56(12):801–805.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Aguilar M, Ramírez-García S, Ilizaliturri-Hernández C, et al. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: a pilot study. Biomed Chromatogr. 2019;33(12):e4684.
   PubMed Web of Science ®Google Scholar
• Bregy L, Nussbaumer-Ochsner Y, Martinez-Lozano Sinues P, et al. Real-time mass spectrometric identification of metabolites characteristic of chronic obstructive pulmonary disease in exhaled breath. Clin Mass Spectrom. 2018;7:29–35.
   Google Scholar
• Kamal F, Kumar S, Edwards MR, et al. Virus-induced volatile organic compounds are detectable in exhaled breath during pulmonary infection. Am J Respir Crit Care Med. 2021;204(9):1075–1085.
   PubMed Web of Science ®Google Scholar
• Celejewska-Wójcik N, Kania A, Górka K, et al. Eicosanoids and eosinophilic inflammation of airways in stable COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:1415–1424.
   PubMed Web of Science ®Google Scholar
• Shih Y-M, Cooke MS, Pan C-H, et al. Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS. Redox Biol. 2019;20:556–565.
   PubMed Web of Science ®Google Scholar
• Kim DJ, Oh JY, Rhee CK, et al. Metabolic fingerprinting uncovers the distinction between the phenotypes of tuberculosis associated COPD and smoking-induced COPD. Front Med (Lausanne). 2021;8:619077.
   PubMed Web of Science ®Google Scholar
• Huang Q, Hu D, Wang X, et al. The modification of indoor PM(2.5) exposure to chronic obstructive pulmonary disease in Chinese elderly people: a meet-in-metabolite analysis. Environ Int. 2018;121(Pt 2):1243–1252.
   PubMedGoogle Scholar
• Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):5886.
   PubMed Web of Science ®Google Scholar
• Gillenwater LA, Kechris KJ, Pratte KA, et al. Metabolomic profiling reveals sex specific associations with chronic obstructive pulmonary disease and emphysema. Metabolites. 2021;11(3):161.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li Q, Liu C, et al. Plasma metabolomics and lipidomics reveal perturbed metabolites in different disease stages of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:553–565.
   PubMed Web of Science ®Google Scholar
• Mastej E, Gillenwater L, Zhuang Y, et al. Identifying protein-metabolite networks associated with COPD phenotypes. Metabolites. 2020;10(4):124.
   PubMed Web of Science ®Google Scholar
• Gillenwater LA, Pratte KA, Hobbs BD, et al. Plasma metabolomic signatures of chronic obstructive pulmonary disease and the impact of genetic variants on phenotype-driven modules. Netw Syst Med. 2020;3(1):159–181.
   PubMedGoogle Scholar
• Cruickshank-Quinn CI, Jacobson S, Hughes G, et al. Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD. Sci Rep. 2018;8(1):17132.
   PubMedGoogle Scholar
• Pinto-Plata V, Casanova C, Divo M, et al. Plasma metabolomics and clinical predictors of survival differences in COPD patients. Respir Res. 2019;20(1):219.
   PubMed Web of Science ®Google Scholar
• Hodgson S, Griffin TJ, Reilly C, et al. Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease. BMJ Open Respir Res. 2017;4(1):e000180.
   PubMed Web of Science ®Google Scholar
• Halper-Stromberg E, Gillenwater L, Cruickshank-Quinn C, et al. Bronchoalveolar lavage fluid from COPD patients reveals more compounds associated with disease than matched plasma. Metabolites. 2019;9(8):157.
   PubMed Web of Science ®Google Scholar
• Yu B, Flexeder C, McGarrah RW, 3rd, et al. Metabolomics identifies novel blood biomarkers of pulmonary function and COPD in the general population. Metabolites. 2019;9(4):61.
   PubMed Web of Science ®Google Scholar
• Liu D, Meister M, Zhang S, et al. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease. Respir Res. 2020;21(1):242.
   PubMed Web of Science ®Google Scholar
• Callejón-Leblic B, Pereira-Vega A, Vázquez-Gandullo E, et al. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry. Biochimie. 2019;157:111–122.
   PubMed Web of Science ®Google Scholar
• Kilk K, Aug A, Ottas A, et al. Phenotyping of chronic obstructive pulmonary disease based on the integration of metabolomes and clinical characteristics. Int J Mol Sci. 2018;19(3):666.
   PubMed Web of Science ®Google Scholar
• Naz S, Kolmert J, Yang M, et al. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD. Eur Respir J. 2017;49(6):1602322.
   PubMed Web of Science ®Google Scholar
• Hoang QTM, Nguyen VK, Oberacher H, et al. Serum concentration of the phytohormone abscisic acid is associated with immune-regulatory mediators and is a potential biomarker of disease severity in chronic obstructive pulmonary disease. Front Med (Lausanne). 2021;8:676058.
   PubMed Web of Science ®Google Scholar
• Xue M, Zeng Y, Lin R, et al. Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease. Exp Biol Med (Maywood). 2021;246(14):1586–1596.
   PubMed Web of Science ®Google Scholar
• Novotna B, Abdel-Hamid M, Koblizek V, et al. A pilot data analysis of a metabolomic HPLC-MS/MS study of patients with COPD. Adv Clin Exp Med. 2018;27(4):531–539.
   PubMed Web of Science ®Google Scholar
• van der Does AM, Heijink M, Mayboroda OA, et al. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(3):224–233.
   PubMed Web of Science ®Google Scholar
• Zhu T, Li S, Wang J, et al. Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicine. EPMA J. 2020;11(4):645–659.
   PubMed Web of Science ®Google Scholar
• Esther CR, O’Neal WK, Anderson WH, et al. Identification of sputum biomarkers predictive of pulmonary exacerbations in COPD. Chest. 2022;161(5):1239–1249.
   PubMed Web of Science ®Google Scholar
• Berdyshev EV, Serban KA, Schweitzer KS, et al. Ceramide and sphingosine-1 phosphate in COPD lungs. Thorax. 2021;76(8):821–825.
   Web of Science ®Google Scholar
• Huang Q, Wu X, Gu Y, et al. Detection of the disorders of glycerophospholipids and amino acids metabolism in lung tissue from male COPD patients. Front Mol Biosci. 2022;9:839259.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Choudhury P, Subramani E, et al. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD. Metabolomics. 2019;15(6):87.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Choudhury P, Joshi M, et al. Global metabolome profiling of exhaled breath condensates in male smokers with asthma COPD overlap and prediction of the disease. Sci Rep. 2021;11(1):16664.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Choudhury P, Kaushik SR, et al. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO). Respir Res. 2020;21(1):126.
   PubMed Web of Science ®Google Scholar
• Oh JY, Lee YS, Min KH, et al. Increased urinary L-histidine in patients with asthma-COPD overlap: a pilot study. Int J Chron Obstruct Pulmon Dis. 2018;13:1809–1818.
   PubMed Web of Science ®Google Scholar
• Cai C, Bian X, Xue M, et al. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study. Int J Chron Obstruct Pulmon Dis. 2019;14:1769–1778.
   PubMed Web of Science ®Google Scholar
• Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. 2014;18(11):1269–1278.
   PubMed Web of Science ®Google Scholar
• Li WJ, Zhao Y, Gao Y, et al. Lipid metabolism in asthma: immune regulation and potential therapeutic target. Cell Immunol. 2021;364:104341.
   PubMed Web of Science ®Google Scholar
• Monga N, Sethi GS, Kondepudi KK, et al. Lipid mediators and asthma: scope of therapeutics. Biochem Pharmacol. 2020;179:113925.
   PubMed Web of Science ®Google Scholar
• George L, Brightling CE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016;7(1):34–51.
   PubMed Web of Science ®Google Scholar
• Backman H, Räisänen P, Hedman L, et al. Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys. Clin Exp Allergy. 2017;47(11):1426–1435.
   PubMed Web of Science ®Google Scholar
• Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141(4):1169–1179.
   PubMed Web of Science ®Google Scholar
• Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15(6):28.
   PubMed Web of Science ®Google Scholar
• Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am. 2007;27(4):587–596.
   PubMed Web of Science ®Google Scholar
• Thomsen SF. Genetics of asthma: an introduction for the clinician. Eur Clin Respir J. 2015;2(1):24643.
   PubMed Web of Science ®Google Scholar
• Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6(1):209–224.
   PubMed Web of Science ®Google Scholar
• Gaude GS, Rajesh BP, Chaudhury A, et al. Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India. 2015;32(5):465–472.
   PubMedGoogle Scholar
• Takiguchi Y, Sekine I, Iwasawa S, et al. Chronic obstructive pulmonary disease as a risk factor for lung cancer. World J Clin Oncol. 2014;5(4):660–666.
   PubMedGoogle Scholar
• Xia Y, Cao Y, Xia L, et al. Severe asthma and asthma-COPD overlap: a double agent or identical twins? J Thorac Dis. 2017;9(12):4798–4805.
   PubMed Web of Science ®Google Scholar
• Mishra V, Banga J, Silveyra P. Oxidative stress and cellular pathways of asthma and inflammation: therapeutic strategies and pharmacological targets. Pharmacol Ther. 2018;181:169–182.
   PubMed Web of Science ®Google Scholar
• Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J. 2003;21(1):177–186.
   PubMed Web of Science ®Google Scholar
• Bhatt SP, Balte PP, Schwartz JE, et al. Discriminative accuracy of FEV1: FVC thresholds for COPD-related hospitalization and mortality. JAMA. 2019;321(24):2438–2447.
   PubMed Web of Science ®Google Scholar
• Corcoran SE, O’Neill LAJ. HIF1α and metabolic reprogramming in inflammation. J Clin Invest. 2016;126(10):3699–3707.
   PubMed Web of Science ®Google Scholar
• Engelen MP, Wouters EF, Deutz NE, et al. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(4):859–864.
   PubMed Web of Science ®Google Scholar
• Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015;70(7):683–691.
   PubMed Web of Science ®Google Scholar
• Portelli MA, Hodge E, Sayers I. Genetic risk factors for the development of allergic disease identified by genome-wide association. Clin Exp Allergy. 2015;45(1):21–31.
   PubMed Web of Science ®Google Scholar
• Toncheva AA, Potaczek DP, Schedel M, et al. Childhood asthma is associated with mutations and gene expression differences of ORMDL genes that can interact. Allergy. 2015;70(10):1288–1299.
   PubMed Web of Science ®Google Scholar
• Denden S, Khelil AH, Knani J, et al. Alpha-1 antitrypsin gene polymorphism in chronic obstructive pulmonary disease (COPD). Genet Mol Biol. 2010;33(1):23–26.
   PubMed Web of Science ®Google Scholar
• Silverman EK. Genetics of COPD. Annu Rev Physiol. 2020;82:413–431.
   PubMed Web of Science ®Google Scholar
• Odimba U, Senthilselvan A, Farrell J, et al. Current knowledge of asthma-COPD overlap (ACO) genetic risk factors, characteristics, and prognosis. COPD. 2021;18(5):585–595.
   PubMedGoogle Scholar
• Yadav CB, Srivastava RK, Gangashetty PI, et al. Metabolite diversity and metabolic genome-wide marker association studies (MGWAS) for health benefiting nutritional traits in pearl millet grains. Cells. 2021;10(11):3076.
   PubMed Web of Science ®Google Scholar